Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab.
作者信息
Ostor Andrew J K, Crisp Adrian J, Somerville Margaret F, Scott David G I
机构信息
Department of Rheumatology, Addenbrooke's Hospital, Cambridge CB2 2QQ.
出版信息
BMJ. 2004 Nov 27;329(7477):1266. doi: 10.1136/bmj.329.7477.1266.
Abstract
摘要
相似文献
1
Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab.使用英夫利昔单抗的类风湿关节炎相关纤维化肺泡炎患者出现致命性病情加重。
BMJ. 2004 Nov 27;329(7477):1266. doi: 10.1136/bmj.329.7477.1266.
2
[TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports].[肿瘤坏死因子阻断剂治疗类风湿性关节炎可引发严重的纤维化肺泡炎。六例病例报告]
Lakartidningen. 2005;102(49):3788-90, 3793.
3
Fatal fibrosing alveolitis with certolizumab.使用赛妥珠单抗导致的致命性肺纤维化
Rheumatology (Oxford). 2012 May;51(5):953-5. doi: 10.1093/rheumatology/ker452. Epub 2012 Feb 10.
4
[Fibrosing alveolitis after treatement of rheumatoid arthritis by infliximab].英夫利昔单抗治疗类风湿关节炎后出现的纤维化肺泡炎
Presse Med. 2009 Oct;38(10):e17-20. doi: 10.1016/j.lpm.2008.12.031. Epub 2009 May 17.
5
[2 cases of fibrosing alveolitis in patients with rheumatoid arthritis treated with chrysanol].
Klin Med (Mosk). 1990 Sep;68(9):99-100.
6
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis.英夫利昔单抗治疗一名类风湿性关节炎合并肺纤维化患者
Eur Respir J. 2004 Oct;24(4):708. doi: 10.1183/09031936.04.00076904.
7
Rate and causes of infliximab discontinuation in patients with rheumatoid arthritis in a private clinical practice.私立临床实践中类风湿关节炎患者英夫利昔单抗停药率及原因
J Clin Rheumatol. 2008 Dec;14(6):313-7. doi: 10.1097/RHU.0b013e31817a7e0e.
8
Severe interstitial pneumonitis associated with infliximab therapy.与英夫利昔单抗治疗相关的严重间质性肺炎。
Scand J Rheumatol. 2004;33(4):276-7. doi: 10.1080/03009740410005836.
9
Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.类风湿关节炎患者使用英夫利昔单抗治疗的肺部并发症
J Rheumatol. 2006 Mar;33(3):622-8.
10
Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.英夫利昔单抗治疗三年后类风湿关节炎患者发生致命性肺结核：对Wolfe等人文章的评论
Arthritis Rheum. 2005 Apr;52(4):1334-6. doi: 10.1002/art.20973.
引用本文的文献
1
Profiles and influencing factors of pulmonary fibrosis associated with biologic and conventional disease-modifying antirheumatic drugs for autoimmune diseases: a disproportionality study based on FAERS and VigiAccess.自身免疫性疾病生物制剂和传统改善病情抗风湿药物相关肺纤维化的特征及影响因素：一项基于FAERS和VigiAccess的不成比例性研究
Front Pharmacol. 2025 Sep 25;16:1604895. doi: 10.3389/fphar.2025.1604895. eCollection 2025.
2
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.2021 年美国风湿病学会类风湿关节炎治疗指南。
Arthritis Care Res (Hoboken). 2021 Jul;73(7):924-939. doi: 10.1002/acr.24596. Epub 2021 Jun 8.
3
[Treatment of rheumatic diseases and pulmonary toxicity].[风湿性疾病与肺毒性的治疗]
Pneumologe (Berl). 2018;15(6):404-412. doi: 10.1007/s10405-018-0209-3. Epub 2018 Sep 25.
4
Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis.系统性硬皮病多组织中基因表达谱和蛋白质-蛋白质相互作用网络分析。
BMC Med Genomics. 2019 Dec 27;12(1):199. doi: 10.1186/s12920-019-0632-2.
5
Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?肿瘤坏死因子抑制剂对类风湿关节炎间质性肺疾病的影响：天使还是魔鬼？
Drug Des Devel Ther. 2019 Jul 1;13:2111-2125. doi: 10.2147/DDDT.S204730. eCollection 2019.
6
Successful treatment of infliximab in a patient with scleroderma: a case report.英夫利昔单抗成功治疗一名硬皮病患者：病例报告
Medicine (Baltimore). 2017 Jun;96(22):e6737. doi: 10.1097/MD.0000000000006737.
7
Rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病
Open Access Rheumatol. 2012 Mar 5;4:21-31. doi: 10.2147/OARRR.S14723. eCollection 2012.
8
Association of Single Nucleotide Polymorphisms of PADI4 and HLA-DRB1 Alleles with Susceptibility to Rheumatoid Arthritis-Related Lung Diseases.肽瓜氨酸化酶4（PADI4）单核苷酸多态性及人类白细胞抗原-DRB1（HLA-DRB1）等位基因与类风湿关节炎相关肺部疾病易感性的关联
Lung. 2016 Oct;194(5):745-53. doi: 10.1007/s00408-016-9916-x. Epub 2016 Jul 2.
9
Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.类风湿关节炎合并间质性肺疾病患者的管理：生物抗风湿药物的安全性及肺纤维化评估
Clin Med Insights Circ Respir Pulm Med. 2015 Sep 8;9(Suppl 1):41-9. doi: 10.4137/CCRPM.S23288. eCollection 2015.
10
Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.肿瘤坏死因子-α抑制剂英夫利昔单抗对博来霉素诱导的大鼠肺纤维化的保护作用
Inflammation. 2016 Feb;39(1):65-78. doi: 10.1007/s10753-015-0224-z.
本文引用的文献
1
Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis.关于类风湿关节炎患者在英夫利昔单抗治疗开始后发生的甲氨蝶呤肺炎的评论。
Arthritis Rheum. 2003 Aug 15;49(4):617; author reply 617-8. doi: 10.1002/art.11187.
2
Lung injury linked to etanercept therapy.与依那西普治疗相关的肺损伤。
Chest. 2002 Nov;122(5):1858-60. doi: 10.1378/chest.122.5.1858.
3
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.英夫利昔单抗治疗活动性强直性脊柱炎：一项随机对照多中心试验。
Lancet. 2002 Apr 6;359(9313):1187-93. doi: 10.1016/s0140-6736(02)08215-6.
4
[Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center].[使用抗TNFα抗体治疗克罗恩病——特拉维夫医疗中心的经验]
Harefuah. 2001 Apr;140(4):289-93, 368.
Zotero 插件